Core Laboratories Inc. (NYSE:CLB – Free Report) – Stock analysts at Zacks Research lowered their Q2 2025 EPS estimates for Core Laboratories in a research report issued on Wednesday, March 26th. Zacks Research analyst T. Saha now expects that the oil and gas company will earn $0.21 per share for the quarter, down from their previous estimate of $0.25. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.34 EPS and FY2027 earnings at $1.28 EPS.
Core Laboratories (NYSE:CLB – Get Free Report) last posted its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%.
Check Out Our Latest Stock Report on Core Laboratories
Core Laboratories Stock Up 0.5 %
Core Laboratories stock opened at $15.47 on Friday. The business has a fifty day moving average price of $16.52 and a 200-day moving average price of $18.10. Core Laboratories has a 1-year low of $12.95 and a 1-year high of $25.13. The stock has a market capitalization of $724.41 million, a price-to-earnings ratio of 23.44, a PEG ratio of 0.99 and a beta of 2.38. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71.
Institutional Trading of Core Laboratories
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Assetmark Inc. acquired a new position in Core Laboratories during the fourth quarter valued at $26,000. Smartleaf Asset Management LLC raised its stake in shares of Core Laboratories by 173.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after buying an additional 1,293 shares during the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Core Laboratories by 2,688.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock valued at $42,000 after buying an additional 2,339 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Core Laboratories by 843.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock valued at $57,000 after buying an additional 2,936 shares during the period. Finally, BNP Paribas Financial Markets purchased a new stake in shares of Core Laboratories in the fourth quarter worth about $123,000. Institutional investors and hedge funds own 97.81% of the company’s stock.
Core Laboratories Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.26%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories’s payout ratio is 6.06%.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Stories
- Five stocks we like better than Core Laboratories
- How to Read Stock Charts for Beginners
- 3 Momentum Stocks Near 52-Week Highs to Watch for More Growth
- About the Markup Calculator
- Microsoft’s Big Malaysia Bet Could Pay Off for Investors
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- The 5 Most Oversold Stocks on the Market Are…
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.